Revolution Medicines, Inc.
RVMDWNasdaq
$9.28
↑ +10.3%Jul 17 close · end-of-day
Price
1Y↑ +3614.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.8B
Enterprise Value
-$69.3M
P/E
—
P/S
—
P/B
1.2
EV/EBITDA
—
PEG
—
FCF Yield
-58.3%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$1.4B
Free Cash Flow (TTM)
-$1.1B
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-91.4%
ROIC
—
Debt / Equity
—
Net Cash
$1.9B
Return 1Y
+3340.3%
Company profile
Management & directors
- Anders JackChief Financial Officer
- Horn Margaret AChief Operating Officer
- Cislini JeffGeneral Counsel
- Goldsmith Mark ASee Remarks
- Kelsey Stephen MichaelSee Remarks
- Mancini AnthonySee Remarks
- Wang XiaolinSee Remarks
- Wei LinChief Medical Officer
Roles derived from SEC Form 4 filings.
Earnings
RVMDW Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$2.29↑ +102.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $43.0M | $29.4M | $35.4M | $11.6M | $0.00 | $0.00 |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$110.7M | -$188.0M | -$258.3M | -$487.2M | -$689.5M | -$1.2B |
| Net income | -$108.2M | -$187.0M | -$249.0M | -$436.0M | -$600.0M | -$1.1B |
| Diluted EPS | -$2.01 | -$2.57 | -$3.08 | -$3.86 | -$3.58 | -$5.95 |
| Operating cash flow | -$100.1M | -$147.2M | -$224.4M | -$350.6M | -$557.4M | -$897.7M |
| Free cash flow | -$103.0M | -$153.7M | -$235.2M | -$358.3M | -$567.7M | -$913.7M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -257.5% | -639.7% | -730.0% | -4207.1% | — | — |
| Net margin | -251.6% | -636.3% | -703.8% | -3765.1% | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$156.6M | -$175.7M | -$216.3M | -$240.8M | -$264.7M | -$315.3M | -$361.6M | -$445.2M |
| Net income | -$133.2M | -$156.3M | -$194.5M | -$213.4M | -$247.8M | -$305.2M | -$364.6M | -$453.8M |
| Diluted EPS | -$0.81 | -$0.94 | -$1.13 | -$1.13 | -$1.31 | -$1.61 | -$1.90 | -$2.29 |
| Operating cash flow | -$128.2M | -$130.4M | -$138.3M | -$194.4M | -$221.8M | -$207.3M | -$274.2M | -$354.2M |
| Free cash flow | -$130.6M | -$133.9M | -$139.5M | -$197.7M | -$229.2M | -$210.7M | -$276.2M | -$355.7M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Coming soonHeadlines for RVMDW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-29 | Patel Sushil | Sale | 1,100 | $185.90 | $204,489.01 | filing |
| 2026-06-29 | Patel Sushil | Sale | 881 | $192.61 | $169,692.85 | filing |
| 2026-06-29 | Patel Sushil | Sale | 900 | $184.59 | $166,128.21 | filing |
| 2026-06-29 | Patel Sushil | Sale | 858 | $186.92 | $160,373.67 | filing |
| 2026-06-29 | Patel Sushil | Sale | 600 | $190.55 | $114,327.00 | filing |
| 2026-06-29 | Patel Sushil | Option exercise | 2,955 | $37.54 | $110,930.70 | filing |
| 2026-06-29 | Patel Sushil | Sale | 541 | $191.87 | $103,799.56 | filing |
| 2026-06-29 | Patel Sushil | Sale | 300 | $187.83 | $56,348.01 | filing |
| 2026-06-29 | Patel Sushil | Sale | 300 | $183.17 | $54,951.99 | filing |
| 2026-06-29 | Patel Sushil | Sale | 100 | $188.57 | $18,857.00 | filing |
| 2026-06-24 | Anders Jack· Chief Financial Officer | Sale | 9,496 | $168.20 | $1.6M | filing |
| 2026-06-24 | Anders Jack· Chief Financial Officer | Sale | 5,651 | $169.24 | $956,398.41 | filing |
| 2026-06-24 | Anders Jack· Chief Financial Officer | Sale | 4,553 | $167.35 | $761,921.79 | filing |
| 2026-06-24 | Anders Jack· Chief Financial Officer | Option exercise | 20,000 | $18.56 | $371,200.00 | filing |
| 2026-06-24 | Anders Jack· Chief Financial Officer | Sale | 300 | $170.32 | $51,096.00 | filing |
| 2026-06-18 | ANDERSON ELIZABETH M | Award | 1,191 | $0.00 | $0.00 | filing |
| 2026-06-18 | Horning Sandra | Award | 1,191 | $0.00 | $0.00 | filing |
| 2026-06-18 | Patel Sushil | Award | 1,191 | $0.00 | $0.00 | filing |
| 2026-06-18 | Borellini Flavia | Award | 1,191 | $0.00 | $0.00 | filing |
| 2026-06-18 | Clyburn Frank | Award | 1,191 | $0.00 | $0.00 | filing |
| 2026-06-18 | Kim Lorence H. | Award | 1,191 | $0.00 | $0.00 | filing |
| 2026-06-18 | Borisy Alexis | Award | 1,191 | $0.00 | $0.00 | filing |
| 2026-06-17 | Horn Margaret A· Chief Operating Officer | Sale | 29,600 | $160.12 | $4.7M | filing |
| 2026-06-17 | Horn Margaret A· Chief Operating Officer | Option exercise | 25,725 | $26.50 | $681,712.50 | filing |
| 2026-06-17 | Horn Margaret A· Chief Operating Officer | Option exercise | 3,302 | $29.80 | $98,399.60 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.